© 2021 MJH Life Sciences and OncLive. All rights reserved.
2 Clarke DriveSuite 100Cranbury, NJ 08512
© 2021 MJH Life Sciences™ and OncLive. All rights reserved.
August 9th 2021
Joseph Mikhael, MD, discusses treatment selection for early relapse in multiple myeloma.
Suzanne Lentzsch, MD, discusses the utility of cellular therapies in multiple myeloma.
September 10th 2021
Thomas G. Martin, MD, discusses the potential utility of quadruplet-based regimens in relapsed/refractory multiple myeloma.